Treating Gastrointestinal and Autism Symptoms in Adults with Autism Using Microbiota Transfer Therapy (MTT)

Abstract

The purpose of this study is to determine the safety and efficacy of Microbiota Transfer Therapy for adults with autism and chronic gastrointestinal problems. Scope: The scope of the project is a randomized, double-blind, placebo-controlled trial of MTT for 84 adults with autism. The trial also includes an extension, partial cross-over, and long-term follow-up (6, 12, and 18 months). It includes extensive evaluation of autism-related and gastrointestinal symptoms, evaluation of microbiome composition, and blood safety tests. It includes 84 neurotypical controls (half with GI symptoms, half without) for comparison of baseline microbiota (no treatment for the neurotypical group).

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Sep 01, 2020
Accession Number
AD1116528

Entities

People

  • James B. Adams

Organizations

  • Arizona State University

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Abstracts
  • Biomedical Research
  • Clinical Trials
  • Covid-19
  • Department Of Defense
  • Government Procurement
  • Governments
  • Health Services
  • Institutional Review Board
  • Local Governments
  • Medical Personnel
  • Microbiomes
  • Patent Applications
  • Patents
  • Physicians
  • Research Facilities
  • Sars
  • Standards
  • Technology Transfer
  • Test And Evaluation
  • Therapy
  • Universities
  • Viruses

Readers

  • Child and Adolescent Substance Abuse Science in Autism Spectrum Disorders.
  • Gulf War Illness and Chronic Multisymptom Illness in Veterans.